SYT7 regulates the progression of chronic lymphocytic leukemia through interacting and regulating KNTC1.
Wenjie ZhangJinlan LongPeixia TangKaili ChenGuangyao GuoZezhong YuJie LinLiping LiuRong ZhanZhen-Shu XuPublished in: Biomarker research (2023)
SYT7 regulates the progression of CLL through SYVN1-mediated KNTC1 ubiquitination, which has potential value for molecular targeted therapy of CLL.